Register entryShortage reported
InfoRLife SA
- Registered sites
- 1
- Drug products
- 0
- Live patents
- 12
- Countries
- 1
- Base
- Switzerland
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackagingsterilize
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| InfoRLife SA | CampascioSwitzerland | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3004537783 |
Alert
Products in shortage
8| Drug | Presentation | Availability |
|---|---|---|
| Metronidazole Injection | Metronidazole, Injection, 500 mg/100 mL (NDC 25021-131-82) | Available |
| Metronidazole Injection | Metronidazole in Flexible Container, Injection, 500 mg/100 mL (NDC 0409-0152-24) | Limited Availability |
| Ropivacaine Hydrochloride Injection | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) | Unavailable |
| Ropivacaine Hydrochloride Injection | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) | Limited Availability |
| Ropivacaine Hydrochloride Injection | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) | Available |
| Ropivacaine Hydrochloride Injection | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) | Available |
| Ropivacaine Hydrochloride Injection | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) | Available |
| Ropivacaine Hydrochloride Injection | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) | Available |
Exclusivity
Patents
12Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| MIDAZOLAM IN 0.9% SODIUM CHLORIDE | MIDAZOLAM | Jun 2038 |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | Feb 2035 |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | Apr 2039 |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.